Oculomotor Technologies offers a vision therapy tool for optometry practices to treat convergence insufficiency.
Oculomotor Technologies has raised $75K in total funding. The most recent round was Grant. The last funding was announced in October 2024.
Oculomotor Technologies's investors include National Science Foundation, Commission on Science, Innovation and Technology.
Oculomotor Technologies is headquartered in Newark, United States.
Oculomotor Technologies offers a vision therapy tool for optometry practices to treat convergence insufficiency.
Oculomotor Technologies is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oculomotor Technologies — Funding & Investors." VCBacked, October 15, 2024, https://www.vcbacked.co/company/oculomotor-technologies. Accessed August 14, 2026.
VCBacked. (2024). Oculomotor Technologies — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/oculomotor-technologies
{{cite web |title=Oculomotor Technologies — Funding & Investors |url=https://www.vcbacked.co/company/oculomotor-technologies |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated